Matches in Wikidata for { <http://www.wikidata.org/entity/Q85790089> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q85790089 description "artículu científicu espublizáu n'ochobre de 2014" @default.
- Q85790089 description "bài báo khoa học" @default.
- Q85790089 description "scientific article published on 14 October 2014" @default.
- Q85790089 description "wetenschappelijk artikel" @default.
- Q85790089 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q85790089 name "Reply to the letter to the editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al" @default.
- Q85790089 name "Reply to the letter to the editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al" @default.
- Q85790089 type Item @default.
- Q85790089 label "Reply to the letter to the editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al" @default.
- Q85790089 label "Reply to the letter to the editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al" @default.
- Q85790089 prefLabel "Reply to the letter to the editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al" @default.
- Q85790089 prefLabel "Reply to the letter to the editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al" @default.
- Q85790089 P1433 Q85790089-B5C933E8-76CB-4099-872C-8F1ECCF3509D @default.
- Q85790089 P1476 Q85790089-8F855582-141E-46DF-92DA-0426A1E9C5CA @default.
- Q85790089 P2093 Q85790089-0521AFAF-E484-438A-9ABB-188282D089BF @default.
- Q85790089 P2093 Q85790089-59CE349C-ADC5-4456-9D1D-6C3F3ADF7D11 @default.
- Q85790089 P2093 Q85790089-BF354C5A-4B76-472E-AC37-D1D4B192E60A @default.
- Q85790089 P304 Q85790089-9881E27A-F607-4A00-A839-AF71EB06776A @default.
- Q85790089 P31 Q85790089-5C6D0233-8581-4EE0-BB3A-9531E5ED0E68 @default.
- Q85790089 P356 Q85790089-34725301-F907-4577-9EB6-8BDD4478B88B @default.
- Q85790089 P433 Q85790089-0AA24FB1-2BB7-45FA-9656-BA107567D89B @default.
- Q85790089 P478 Q85790089-CECB8879-7DF6-49F6-98BF-4D727EBDFE11 @default.
- Q85790089 P577 Q85790089-5BE5F3CB-2F99-4E3E-8539-495E008646BC @default.
- Q85790089 P698 Q85790089-F1387CB6-C959-46B7-B87B-2C9947697D03 @default.
- Q85790089 P921 Q85790089-4AADBC1D-1CC7-4402-8350-E7D941236F78 @default.
- Q85790089 P356 MDU476 @default.
- Q85790089 P698 25316256 @default.
- Q85790089 P1433 Q326122 @default.
- Q85790089 P1476 "Reply to the letter to the editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al" @default.
- Q85790089 P2093 "K Sugihara" @default.
- Q85790089 P2093 "M Ishiguro" @default.
- Q85790089 P2093 "M Yoshida" @default.
- Q85790089 P304 "245-246" @default.
- Q85790089 P31 Q13442814 @default.
- Q85790089 P356 "10.1093/ANNONC/MDU476" @default.
- Q85790089 P433 "1" @default.
- Q85790089 P478 "26" @default.
- Q85790089 P577 "2014-10-14T00:00:00Z" @default.
- Q85790089 P698 "25316256" @default.
- Q85790089 P921 Q422327 @default.